Share: Facebook Twitter LinkedIn
Activity Provided By:

ACHL

Practical Guidance for the Community Oncologist — Incorporating Advances in Therapy for Metastatic TNBC: A Focus on TROP2

Access Activity

Overview / Abstract:

Host a complimentary Virtual Visiting Professorship Program (VPP): Practical Guidance for the Community Oncologist — Incorporating Advances in Therapy for Metastatic TNBC: A Focus on TROP2.

Easy-to-administer one-hour complimentary virtual independent medical education is available to your institution. We will coordinate a day and time that works for your intuition and bring the expert to you.

✔️ No cost to your organization (supported by an educational grant)
✔️ Approved for physician and nurse credit
✔️ Features leading faculty (Hope Rugo, MD, Sara Hurvitz, MD, Ruta Rao, MD, and Sara Tolaney, MD)
✔️ Interactive discussions on the emergence of TROP2-directed antibody drug conjugate (ADC) technology for exciting new targeted treatment approaches

Topic Highlights Include:
• TNBC treatment challenges
• ADC mechanistic rationale
• Role of TROP2 in TNBC
• Case-based application of current data and recommendations

Expiration

May 31, 2022

Discipline(s)

Nurse Practitioner , Nursing CNE, Physician CME, Physician Assistant CME

Format

Grand Rounds, Live / Seminar

Credits / Hours

1.0

Accreditation

ACCME and ANCC

Is This Activity Certified for "Live" Credit?

YES

Presenters / Authors / Faculty

Hope Rugo, MD, FASCO (Chair)
Professor of Medicine
Division of Hematology and Oncology
Director, Breast Oncology and Clinical Trials Education
University of California San Francisco (UCSF) Helen Diller Family Comprehensive Cancer Center
San Francisco, CA

Sara Hurvitz, MD, FACP (Faculty)
Professor of Medicine
University of California, Los Angeles (UCLA)
Co-Director, Santa Monica-UCLA Outpatient Oncology Practice
Medical Director, Clinical Research Unit
Jonsson Comprehensive Cancer Center at UCLA
Director of Breast Oncology
Simms/Mann UCLA Center for Integrative Oncology
Los Angeles, CA

Ruta Rao, MD (Faculty)
Professor of Medicine
Department of Internal Medicine, Division of Hematology, Oncology and Cell Therapy
Rush Medical College
Director, Coleman Foundation Comprehensive Breast Cancer Clinic
Medical Director, Rush University Cancer Center
Chicago, IL

Sara Tolaney, MD, MPH (Faculty)
Associate Professor of Medicine
Harvard Medical School
Chief, Division of Breast Oncology
Associate Director, Susan F Smith Center for Women's Cancers
Dana-Farber/Brigham and Women's Cancer Center
Boston, MA

Activity Specialities / Related Topics

OB/GYN / Women's Health, Oncology / Cancer / Radiation Therapy

Sponsors / Supporters / Grant Providers

Sponsored by Rush University Medical Center and the Academy for Continued Healthcare Learning (ACHL)

Keywords / Search Terms

ACHL Hope Rugo, MD, Sara Tolaney, MD, MPH, triple negative breast cancer, TNBC, Trop2, antibody drug conjugate (ADC), oncologists, oncology, estrogen receptor, progesterone receptor, HER2, BRCA1/2, breast cancer, metastasis, relapse, cytotoxic chemotherapy, anthracyclines, alkylators, taxanes, neoadjuvant chemotherapy, poly ADP-ribose polymerase (PARP) inhibitors, monoclonal antibody, transmembrane glycoprotein, PD-L1 expression Free CE CME Live CE CME Seminar CE CME

LIVE Activity Location Details

Date(s)
11-01-2021 - 05-31-2022

Virtual- Choose a Day/Time that Works Best for YOUR Organization
N/A
N/A   N/A
United States of America

Access Activity

CORE Higher Education Group, CESearchEngine.com, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the CESearchEngine.com website or within our mobile apps.CORE Higher Education Group, CESearchEngine.com, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or within our mobile apps. For complete details, please read the CESearchEngine.com Terms of Service. Site Map